Forge Biologics, Case Western train gene therapy workers

By The Science Advisory Board staff writers

July 6, 2021 -- Contract development and manufacturing organization Forge Biologics and Case Western Reserve University in Cleveland announced that they will collaborate on a gene therapy workforce development program.

The program is called Forge Forward and is a partnership with the university's National Center for Regenerative Medicine (NCRM). Its goal is to attract researchers with good manufacturing practice (GMP) training to work with Forge on gene therapy.

Candidates selected for the program will learn how to work in both research and GMP environments. They will also get hands-on experience in cell culture and sterile techniques through lecture and laboratory teaching.

Copyright © 2021

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.